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ORIGINAL ARTICLE
Prior Helicobacter pylori Infection Ameliorates Salmonella
Typhimurium-Induced Colitis: Mucosal Crosstalk Between
Stomach and Distal Intestine*
Peter D.R. Higgins, MD, PhD, MSc, Laura A. Johnson, MS, Jay Luther, MD, Min Zhang, MD,
Kay L. Sauder, MD, Luz P. Blanco, MD, and John Y. Kao, MD
Background: Helicobacter pylori infection is associated with a
lower risk of chronic autoimmune diseases including inflamma-
tory bowel disease (IBD). H. pylori modulates the gastric immune
response, decreasing the local inflammatory response to itself. In
mice, chronic Salmonella typhimurium infection induces colitis
similar to Crohn’s disease, characterized by inflammation, which
progresses toward fibrosis. The aim of this study was to determine
whether prior H. pylori infection acts at a distance to modulate
the immune response of S. typhimurium-induced colitis.
Methods: Mice were infected with the mouse-adapted strain of
H. pylori (SS1), followed by infection with S. typhimurium. The
effect of H. pylori on colitis was determined by gross pathology,
histopathology, cytokine response, and development of fibrosis in
the cecum. Gastritis and systemic immune response was measured
in response to infection.
Results: H. pylori suppresses the Th17 response to S. typhimu-
rium infection in the mouse cecum, but does not alter the Th2 or
T-regulatory response or the development of fibrosis. H. pylori
infection induces IL-10 in the mesenteric lymph nodes, suggesting
an extragastric mechanism for immunomodulation. H. pylori / S.
typhimurium coinfection decreases inflammation in both the ce-
cum and the stomach.
Conclusions: This study demonstrates a potential mechanism
for the negative association between H. pylori and IBD in
humans. H. pylori represses the lower gastrointestinal tract Th17
response to bacterially induced colitis via extragastric immunomo-
dulatory effects, illustrating immunological crosstalk between the
upper and lower gastrointestinal tract.
(Inflamm Bowel Dis 2011;17:1398–1408)
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H elicobacter pylori is a Gram-negative bacterium thatfrequently and chronically colonizes the human gastric
mucosa. H. pylori’s capacity to cause chronic infection
stems from its ability to modulate the gastric immune
response. Recent data demonstrate that H. pylori upregulates
the production of antiinflammatory T-regulatory (Treg) cells
in the stomach, thereby decreasing the inflammatory
response against the bacteria.1 In fact, H. pylori-colonized
patients express higher levels of gastric Foxp3, a Treg cell
marker.2 Whether this upregulation affects systemic immune
responses in addition to the local response against H. pylori
is unknown. However, colonization with H. pylori has been
inversely associated with certain chronic inflammatory dis-
eases, such as asthma and lupus.3 This suggests that
immune regulation by H. pylori may have systemic effects.
Inflammatory bowel disease (IBD) is a chronic
inflammatory condition of the intestinal tract, resulting in
part from a dysregulated immune response. Previous work
in animal models has illustrated the importance of Treg
cells in the pathogenesis of colitis. For example, mice defi-
cient in IL-10, a key regulatory cytokine of Treg cells, de-
velop spontaneous colitis.4 Additionally, adoptive transfer
of Treg cells can inhibit the development of colitis in cer-
tain animal models.5–7 Furthermore, a meta-analysis of
studies investigating the relation between H. pylori coloni-
zation and IBD found a significant inverse association
between the two, suggesting a possible protective role for
H. pylori8 colonization against the development of IBD.
However, these clinical data have various confounders,
limiting the certainty of the findings.
In this study we aimed to examine the effect of H.
pylori on an experimental model of colitis and further
define the relationship between H. pylori and IBD. We
used the Salmonella typhimurium model of colitis in order
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to illustrate the effect of gastric H. pylori colonization on
a distant bacterial–host immune system interaction in the
colon.9 We found that H. pylori infection decreased
cecal inflammatory cytokine expression in response to
S. typhimurium infection. We also found that prior H.
pylori infection influences distal mucosal immune
responses, as evidenced by an increased interleukin (IL)-10
expression measured in the mesenteric lymph nodes of
mice infected with H. pylori. Our data provide the first evi-
dence that H. pylori infection in the stomach alters the
immunological environment of the lower gastrointestinal
(GI) tract, providing mechanistic support for the epidemio-
logical observation of a negative association between H.
pylori status and risk of IBD.
MATERIALS AND METHODS
Mice
Female 8–12-week-old C57/BL6 mice (Jackson Labo-
ratories, Bar Harbor, ME) were infected with either
H. pylori SS1, S. typhimurium DaroA or H. pylori SS1 þ S.
typhimurium DaroA. Twenty-four hours prior to oral infec-
tion with 3  106 colony-forming units (CFU) of S. typhi-
murium strain DaroA in 100 lL 0.1 M HEPES buffer (pH ¼
8.0), mice received 20 mg of streptomycin in 0.1 M Hank’s
balanced salt solution (HBSS) by oral gavage. All animal
experiments were conducted with the approval and oversight
of the University of Michigan UCUCA (University Commit-
tee on Use and Care of Animals).
Bacterial Strains
Salmonella typhimurium strain DaroA (a gift from
Guntram Grassl, University of British Columbia, Vancouver,
BC, Canada) which is naturally resistant to streptomycin was
grown in LB broth containing 100 lg/mL streptomycin at
37C. The mouse-adapted H. pylori SS1 strain (a gift from
Kathryn Eaton, University of Michigan, Ann Arbor, MI) was
grown on Campylobacter-selective agar (BD Diagnostics,
Bedford, MA) supplemented with 5% sterile horse blood, tri-
methoprim (5 lg/mL), vancomycin (10 lg/mL), and nystatin
(10 lg/mL) for 2 days at 37C in a humidified microaero-
philic chamber (BBL Gas System, with CampyPak Plus
packs; BD Microbiology, Sparks, MD).
Animal Studies
Mice were infected with H. pylori SS1 with an oral
gavage of 108 CFU of live organisms thrice over 1 week.
Control animals received HBSS by oral gavage. Thirty-four
days after the H. pylori infection, half of the H. pylori-
infected animals (H. pylori/S. typhimurium) received 20 mg
streptomycin by oral gavage followed by infection with 3
 106 CFU S. typhimurium DaroA in 100 k 0.1 M HEPES
buffer (pH ¼ 8.0) (Supporting Fig. 1). The other half of
the H. pylori-infected cohort (H. pylori group) was not
infected with S. typhimurium but received streptomycin and
HBSS on the same schedule. Of the animals uninfected
with H. pylori, half received streptomycin and subsequent
S. typhimurium infection (S. typhimurium group). Negative
control (HBSS group) animals were not infected with S.
typhimurium but received streptomycin and HBSS. Mice
were euthanized 21 days post S. typhimurium infection.
Gross Pathology and Tissue Collection
Mice were euthanized at 21 days post-S. typhimurium
infection. Cecum and distal colon were collected, photo-
graphed, measured, and weighed. Cecal area was determined
from digital photographs using ImageJ (NIH, Bethesda,
MD) and a defined region of interest (ROI) to delineate the
cecum. To control for differences in images, the cecal area
was normalized against a 1-cm marker in the photographic
image. Tissues were snap-frozen in liquid nitrogen and
stored at 80C prior to molecular analysis. Cecal contents
were collected and serially diluted before plating onto LB-
streptomycin plates to determine bacterial titers.
Histology
Formalin-fixed and paraffin-embedded tissues were
stained with hematoxylin and eosin (H&E, inflammatory
histology) and Masson’s trichrome (fibrosis) by the Univer-
sity of Michigan CCGC Research Histology and Immuno-
peroxidase Laboratory (Ann Arbor, MI). Digital photomi-
crographs of tissue sections were taken with an Olympus
BX microscope (University of Michigan Microscopy and
Image Analysis Laboratory). Histological scoring was per-
formed by two blinded observers (J.K., J.L.). Tissue meas-
urements were quantitated with ImageJ analysis software.
Histological Scoring
Gastric tissue was scored for inflammation on a scale
of 0 ¼ none to 3 ¼ marked by the Modified Sydney
Approach.10 Cecal inflammation was determined using a
separate scoring system11: (0) no inflammation; (1) low
level of inflammation with scattered infiltrating mononu-
clear cells; (2) moderate inflammation with multiple foci;
(3) high level of inflammation with increased vascular den-
sity and marked wall thickening; (4) maximal severity of
inflammation with transmural leukocyte infiltration and loss
of goblet cells.
Immunoblotting
Immunoblotting was utilized for the detection of
a-smooth muscle actin (aSMA). Whole tissue was pulver-
ized under liquid nitrogen and lysed in ice-cold RIPA buffer
with a cocktail of proteinase inhibitors (Roche, Indianapo-
lis, IN). Protein content was determined using a modified
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Bradford assay kit (BioRad, Hercules, CA). Total protein
was separated by sodium dodecyl sulfate (SDS) polyacryl-
amide gel electrophoresis and transferred to PVDF
membranes (Amersham Biosciences, Piscataway, NJ).
Membranes were blocked in 5% milk solution for 1 hour at
room temperature or overnight at 4C. a-SMA was detected
by incubating the membrane overnight at 4C with mouse
antihuman monoclonal antibody (Sigma, St. Louis, MO) at
1:5000 dilution in 5% milk/TBST. As a loading control, a
mouse antibody for GAPDH (Chemicon, Temecula, CA)
was used after a stripping procedure. Secondary antibody
antimouse IgGþ HRP (Amersham, Piscataway, NJ) was
incubated for one hour at room temperature and the signal
was detected by the Pierce detection system (Rockford, IL).
Autoradiographs were scanned and quantitated using Image
J analysis software.
Meta-analysis
The relative risk (RR) of H. pylori infection in IBD
versus controls was determined from 26 observational stud-
ies as previously described.8 Briefly, RR was used to
describe the ratio of the probability of the H. pylori infec-
tion occurring in IBD patients versus the controls. The RR
was calculated with a 95% confidence interval (CI) based
on a random-effects model as described by Mantel-Haens-
zel.12 Meta-analysis was performed with the metan com-
mand in Stata 10.1 (StataCorp, College Station, TX).
Real-time Quantitative Polymerase Chain
Reaction (PCR)
RNA was extracted from the cecum using the
RNeasy kit (Qiagen, Valencia, CA). Reverse transcription
of 2 lg of total RNA was performed with the Superscript
FIGURE 1. H. pylori infection is negatively associated with the relative risk for developing IBD in human populations. The
summary RR was calculated from 26 studies based on a random effects model. Horizontal lines delineate the upper and
lower confidence limits with diamonds indicating the point estimates. The area of the gray rectangular boxes corresponds
to the weight of the study in the meta-analysis. RR is shown in the right column with upper and lower 95% CIs in parenthe-
ses. The pooled RR estimate (Overall) is shown at the bottom (P < 0.0001). The solid vertical line represents no effect.
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FIGURE 2. H. pylori infection suppresses the Th17 cytokine response in the cecum. (A) Representative gross appearance of
the cecum and distal colon of H. pylori-infected mice compared to uninfected (no Tx), S. typhimurium-infected (St) and H.
pylori / S. typhimurium (StþHp) infected with a 1-cm reference ruler. (B) H&E-stained histological sections (100 magnifica-
tion). Infection with S. typhimurium induces substantial submucosal expansion, collagen deposition, epithelial destruction,
and inflammatory infiltration. Scale bar ¼ 200 lm. (C–H) qRT-PCR gene expression of Th1 and inflammatory cytokines in the
cecum of uninfected (no Tx) compared to H. pylori (Hp), S. typhimurium (St), and H. pylori / S. typhimurium (StþHp) infected
mice. The markers of innate immune response IL-1b (C) and TNF-a (D) are compared to markers of the adaptive immune
response IL-12p40 (E), IL-6 (F), IFN-c (G), and IL-17 (H). Gene expression was normalized to GAPDH expression. The results
are from two independent animal experiments. Numbers (n) below the graph labels represent number of animals per experi-
mental group (ns ¼ not significant, *P < 0.05, **P < 0.01, ***P < 0.001). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
First Strand RT kit (Invitrogen, Carlsbad, CA). Quantitative
real-time PCR (qPCR) of IL-1b, tumor necrosis factor
alpha (TNF-a), interferon gamma (IFN-c), IL-17, IL-6, IL-
13, IL-12p40, Foxp3, IL-10, IL-4, TGF-b, and GAPDH
was performed with the TaqMan gene expression assays
(ABI, Foster City, CA). Quantitative PCR was performed
using a Stratagene Mx3000P real-time PCR system (La
Jolla, CA). Cycling conditions were 95C 10 minutes, fol-
lowed by 40 cycles of 95C 15 seconds and 62C 60 sec-
onds. DDCt were calculated from GAPDH expression.
Statistical Analysis
Comparisons between several groups of mice and
associated tissues or RNA expression were analyzed with
analysis of variance (ANOVA), while pairwise compari-
sons of two groups were performed with Student’s t-test.
RESULTS
H. pylori Infection Is Negatively Associated with
the RR for Developing IBD in Human Populations
An update of our previously published meta-analysis
of 24 observational studies was performed to include an
additional two new studies.1 The overall RR of developing
IBD in patients infected with H. pylori was 0.63 (95% CI;
0.54–0.73, P < 0.001, Fig. 1). This observation suggests
that H. pylori infection is protective against the develop-
ment of IBD.
H. pylori Infection Suppresses the Th17 Cytokine
Response in the Cecum
To examine the effect of H. pylori gastric infection
on distal gut inflammation, H. pylori-infected mice were
coinfected with S. typhimurium. Chronic infection with
S. typhimurium is characterized by a dramatic reduction in
cecal size and a concurrent increase in tissue inflamma-
tion.9 Mice infected with either S. typhimurium or coin-
fected with H. pylori / S. typhimurium developed marked
changes in cecal appearance compared to either the unin-
fected or H. pylori-infected mice (Fig. 2A). H&E histologi-
cal sections of cecal tissue from S. typhimurium or
H. pylori / S. typhimurium-infected animals exhibited
extensive crypt loss, inflammatory infiltration, transmural
inflammation, and hypertrophy in the muscularis propria,
findings that were not present in uninfected or H. pylori-
infected controls (Fig. 2B). S. typhimurium infection elicits
both innate (IL-1b and TNF-a) and adaptive (IL-12p40, IL-
6, IFN-c, and IL-17) responses in the cecum (Fig. 2C–H).
H. pylori / S. typhimurium coinfection significantly
repressed IL-6 and IL-17 mRNA expression (3-fold and
5.3-fold, respectively) in the cecum, with a trend toward
lower IL-1b and TNF-a in the cecum compared to infec-
tion by S. typhimurium alone. As expected, H. pylori
infection alone did not significantly induce these proinflam-
matory cytokines in the cecum except for a small but sig-
nificant rise in IFN-c expression. Overall, gastric H. pylori
infection significantly downregulates the cecal Th17
response to S. typhimurium infection.
H. pylori Gastric Colonization and S. typhimurium
Cecal Colonization Are Not Altered by Coinfection
To examine whether H. pylori suppression of S. typh-
imurium colitis is caused by a reduction in the level of S.
typhimurium cecal colonization, the effect of H. pylori
infection upon S. typhimurium cecal colonization was
determined. S. typhimurium heavily colonizes the mouse
cecum, persisting at day 21 postinfection. Luminal cecal
contents were isolated from uninfected, S. typhimurium, H.
pylori, and H. pylori / S. typhimurium coinfected mice. De-
spite prior H. pylori infection, S. typhimurium cecal coloni-
zation did not differ between S. typhimurium-infected and
H. pylori / S. typhimurium coinfected mice (Fig. 3). There-
fore, H. pylori suppression of the Th17 response to S. typh-
imurium was not due to a decrease in S. typhimurium colo-
nization of the cecum.
To investigate further the mechanism of H. pylori’s
effect on distal GI tract, we studied whether H. pylori
could colonize the mouse cecum, allowing it to directly
FIGURE 3. H. pylori gastric colonization and S. typhimurium
cecal colonization are not altered by coinfection. (A) S. typh-
imurium colonizes the mouse cecum, irrespective of
H. pylori coinfection. Colonization was determined from
serial dilutions of 100 lL of cecal contents of uninfected
(no Tx), H. pylori (Hp), S. typhimurium (St), and H. pylori /
S. typhimurium-infected mice cultured on LB/streptomycin
plates. The results are from two independent animal experi-
ments. Statistical comparisons are made to the uninfected
group (ns ¼ not significant, **P < 0.01).
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suppress local mucosal immune responses. First, levels of
gastric H. pylori colonization were compared and no differ-
ence was found between H. pylori infection alone versus
coinfection with S. typhimurium by qRT-PCR (Supporting
Fig. 2A). Our data also showed that H. pylori did not colo-
nize the cecum as cecal tissue samples had undetectable
levels of H. pylori urease A measured by quantitative RT-
PCR from either H. pylori or H. pylori / S. typhimurium
coinfected mice (Supporting Fig. 2B).
H. pylori Infection Does Not Alter S. typhimurium-
induced Th2 or Treg Cytokine Responses in the
Mouse Cecum
Another potential mechanism of immune suppression
by H. pylori is by induction of Th2 or Treg responses in
the cecum. H. pylori infection alone did not induce signifi-
cant cecal expression of Th2 cytokines IL-4 and IL-13, but
did induce higher levels of IL-10 and Foxp3 in the cecum
(Fig. 4). During coinfection with S. typhimurium, however,
the H. pylori coinfection was not associated with an
increased cecal IL-10 expression but a trend towards
increased Foxp3 was observed (Fig. 4C,D). H. pylori infec-
tion alone induced significant increases in the expression of
IL-10 and Foxp3 in the cecum, and a mild increase in IL-
13, but had no effect on IL-4 (Fig. 4A,B). During coinfec-
tion with H. pylori and S. typhimurium, there was no fur-
ther increase in cecal IL-10 and Foxp3. Addition of S.
typhimurium did reverse the induction of IL-13 by H.
pylori, to either monoinfection with H. pylori or S. typhi-
murium. These findings suggest that gastric H. pylori’s
immunosuppressive effect at a distance in the cecum may
be related to the immunoregulatory modulation of the Th17
cecal mucosal immune response.
H. pylori Infection Induces IL-10 Expression in the
Mesenteric Lymph Nodes.
To examine whether the immunoregulatory effect of
H. pylori infection in the cecum also occurs in the second-
ary draining lymph nodes, mesenteric lymph nodes
(MLNs) were collected and cytokine profiles compared. As
FIGURE 4. H. pylori infection does not alter S. typhimurium-induced Th2 or Treg cytokine responses in the mouse cecum. (A)
qRT-PCR gene expression of Th2 cytokines, IL-13 (A), and IL-4 (B) in the cecum of uninfected (no Tx) mice compared to H.
pylori (Hp), S. typhimurium (St), and H. pylori / S. typhimurium (StþHp) infected mice. The qRT-PCR expression of Treg cyto-
kines IL-10 (C) and Foxp3 (D) in the cecum. Gene expression was normalized to GAPDH expression. Results are from two in-
dependent animal experiments (ns ¼ not significant, *P < 0.05, **P < 0.01, ***P < 0.001).
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shown in Figure 5A, H. pylori infection increased IL-10
mRNA expression in the MLNs compared to uninfected
mice. During S. typhimurium infection, the levels of MLN
IL-10 decreased and the levels of IL-17 and IFN-c were
increased compared to uninfected mice (Fig. 5B,C). No
significant differences in these cytokine levels were meas-
ured with H. pylori / S. typhimurium coinfection, suggest-
ing a greater influence of H. pylori infection in the cecum
than in the MLNs. This could be due to the presence of H.
pylori antigen traveling through the intestinal lumen and
augmenting the immunoregulatory effect of H. pylori at the
cecal mucosa.
H. pylori Infection Does Not Affect
S. typhimurium-induced Cecal Fibrosis
Chronic S. typhimurium infection produces an intesti-
nal fibrosis phenotype similar to human Crohn’s disease.9
Fibrosis is largely confined to the cecum and is character-
ized by excessive extracellular matrix deposition, submuco-
sal hypertrophy, and myofibroblast activation. S. typhimu-
rium infection induces a marked increase in extracellular
collagen deposition as determined by trichrome staining of
cecal tissue compared to uninfected or H. pylori-infected
mice (Fig. 6A). H. pylori / S. typhimurium coinfection indu-
ces a similar response. Cecal submucosal expansion, a mea-
sure of both edema and fibrosis, was induced 4.7-fold by
S. typhimurium infection compared to uninfected mice (Fig.
6B). H. pylori / S. typhimurium coinfection induced a similar
4.5-fold increase in submucosal thickness, indicating
H. pylori did not alter the fibrogenic response induced by
S. typhimurium (P ¼ 0.01 versus uninfected), while
H. pylori infection alone had no effect. Collagen deposition is
effected by activated resident myofibroblasts which express
aSMA that is mediated by TGF-b during the wound-healing
response. S. typhimurium induces higher aSMA protein and
TGF-b mRNA expression compared to uninfected mice as
determined by Western blotting (Fig. 6C,D). H. pylori /
S. typhimurium coinfection induces similar levels of aSMA
protein TGF-b mRNA expression, comparable to S. typhimu-
rium alone. Therefore, gastric H. pylori coinfection does not
reduce S. typhimurium-induced intestinal fibrosis.
FIGURE 5. H. pylori infection induces IL-10 expression in the
MLNs. qRT-PCR expression of IL-10 (A), IL-17 (B), and IFN-c (C)
in H. pylori-infected mice (Hp) compared to uninfected (no
Tx), S. typhimurium-infected (St) and H. pylori / S. typhimurium
(StþHp) infected. Results are from five animals per experi-
mental group. Cytokine expression was normalized to GAPDH
expression (ns ¼ not significant, *P < 0.05, **P < 0.01).
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FIGURE 6. H. pylori infection does not affect S. typhimurium-induced cecal fibrosis. (A) Trichrome stained histological sections
(5 magnification). Infection with S. typhimurium (St) or H. pylori / S. typhimurium (StþHp) induces substantial increase in
the extracellular matrix characterized by collagen deposition (blue staining) compared to uninfected (no Tx) or H. pylori-
infected (HP). Scale bar ¼ 2 mm. (B) Cecal submucosal thickness measurements. The submucosal thickness was determined
at three reference points from photomicrographs above. Each point represents an individual animal. Horizontal bars indicate
the average submucosal thickness for each experimental group. (C) Representative Western blot illustrating aSMA protein
expression in cecal extracts. GAPDH protein expression was used as a loading control. (D) qRT-PCR gene expression of TGF-b
in the cecum of uninfected (no Tx) compared to H. pylori (Hp), S. typhimurium (St), and H. pylori / S. typhimurium (StþHp)
infected. Gene expression was normalized to GAPDH expression. Results are from two independent animal experiments (ns
¼ not significant, *P < 0.05, **P < 0.01). [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
H. pylori and S. typhimurium Coinfection
Decreases Inflammation in Both the Stomach
and Cecum
H. pylori infection is characterized by gastric hyper-
plasia and inflammatory infiltration in the gastric mucosa.
H&E-stained sections of stomach from H. pylori-infected
mice exhibit hyperplasia and leukocyte infiltration com-
pared to uninfected mice (Fig. 7A). S. typhimurium infec-
tion does not induce gastritis. To assess the extent of H.
pylori induced gastritis, H&E-stained sections of mouse
stomach were scored by two blinded observers using the
Modified Sydney Approach for inflammation.10 Mice
infected with H. pylori developed significant gastritis com-
pared to uninfected mice (2.0 versus 0 points, P < 0.01).
H. pylori / S. typhimurium coinfected mice have a lower
gastritis score than H. pylori-infected mice (Fig. 7B).
While H. pylori infection induces gastritis, H. pylori
effects on the lower GI tract are unknown. H&E-stained
cecal tissue sections were scored by a blinded observer on a
0 to 4 scale11 for mononuclear infiltration, vascular density,
wall thickening, transmural leukocyte infiltration, and loss
of goblet cells (Fig. 7C). Surprisingly, H. pylori infection
alone induces mild cecal inflammation compared to unin-
fected mice (2.4 versus 3.6, P ¼ 0.0009). While mice
infected with S. typhimurium (3.6 versus 0.4, P < 0.0001) or
H. pylori /S. typhimurium (2.4 versus 0.4, P ¼ 0.004) devel-
oped marked cecal inflammation compared to uninfected
controls, H. pylori / S. typhimurium coinfected mice exhib-
ited less cecal inflammation than S. typhimurium-infected
alone (2.4 versus 3.6, P ¼ 0.009). This indicates immuno-
logical crosstalk between the upper and lower GI tract.
DISCUSSION
The incidence of H. pylori infection is highest
among individuals from developing countries and lower in
developed countries. The incidence of IBD has an opposite
trend, raising the possibility of immunological crosstalk
between the stomach and the distal GI tract. In fact, an
update of our previously published meta-analysis8 indicates
FIGURE 7. H. pylori and S. typhimurium coinfection
decreases inflammation in both the stomach and cecum.
(A) H&E histological sections (100 magnification). Infection
with H. pylori (Hp) induces gastric hyperplasia and inflam-
matory infiltration compared to uninfected (no Tx), S. typhi-
murium (St), and H. pylori / S. typhimurium (StþHp) infected
mice. Scale bar ¼ 200 lm. (B) H. pylori-induced inflamma-
tion in the stomach is repressed by S. typhimurium infec-
tion. Gastritis was scored from H&E-stained sections of
stomach using the Modified Sydney Approach on a scale of
0 (normal) to 3 (marked inflammation). (C) H. pylori infection
represses S. typhimurium-induced inflammation in the ce-
cum. Cecal inflammation was determined from H&E-stained
sections of cecum were scored (0) no inflammation, (1) low
level of inflammation with scattered infiltrating mononu-
clear cells, (2) moderate inflammation with multiple foci (3)
high level of inflammation with increased vascular density
and marked wall thickening, (4) maximal severity of inflam-
mation with transmural leukocyte infiltration and loss of
goblet cells. Results are from two independent animal
experiments (ns ¼ not significant, *P < 0.05, **P < 0.01,
***P < 0.001). [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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the overall relative risk (0.63) of developing IBD in
patients infected with H. pylori remains significantly less
than uninfected individuals. To investigate the mechanism
for the inverse association observed between H. pylori sta-
tus and the risk of developing IBD, we examined the
effect of H. pylori infection on the immunological
responses in the lower GI tract and in a mouse model of
S. typhimurium typhlitis. We showed that mice chronically
infected with H. pylori had a significantly elevated IL-10
mRNA expression in the cecum and in the MLNs, indicat-
ing H. pylori induces immunoregulatory responses in the
lower GI tract. Additional supporting evidence is the find-
ing that a lower cecal Th17 response and a repressive
trend in the innate immune response was measured in
mice coinfected with H. pylori and S. typhimurium com-
pared to infection with S. typhimurium alone. This was not
due to a difference in Salmonella colonization of the cecum
nor to differences in IL-13, IL-4, or IL-10 cytokine levels.
No significant difference in fibrosis was detected between
the two groups, suggesting selective immunomodulation. Of
note, we did observe decreased gastric inflammation in
mice coinfected with H. pylori and Salmonella, indicating a
potential crosstalk between distant GI sites colonized by
different bacteria.
The ability of H. pylori to colonize the stomach
depends on its expression of BabA, which enables it to
anchor on gastric epithelium.13 There is no evidence that
H. pylori colonizes the intestine, except in regions with
gastric heterotypia,14 which further supports the gastric
specificity of H. pylori colonization. We further verified by
PCR the absence of H. pylori in the cecal specimens of
H. pylori colonized mice. Thus, we speculate that H. pylori
potentially influences the distal GI tract through systemic
immunomodulation. Epidemiological data also supports
this concept as a negative association between H. pylori
status and asthma has been reported.15
A potential mechanism for the observed H. pylori
immune modulation in the distal gut is the regulation of mu-
cosal immune response owing to the tolerogenic properties
of H. pylori.1 H. pylori-infected patients were found to have
higher gastric expression of Foxp3, a regulatory T cell
marker, than uninfected individuals.2 In fact, H. pylori-
infected children with a lower degree of gastritis expressed
higher levels of Foxp3 than infected adults with more severe
gastritis,16 indicating that the H. pylori-induced regulatory
T-cell response might play a critical role in downmodulating
mucosal inflammation. This response is not limited to the
gastric mucosa, as it has been shown to play a critical role in
peripheral T-cell anergy in H. pylori-infected patients.17 Our
study further supports the systemic nature of H. pylori
induced Treg responses by showing an increased IL-10
expression in the MLNs of H. pylori-infected mice. This pro-
vides the critical missing mechanism to explain the observed
negative association between H. pylori status and the devel-
opment of IBD. We showed further that H. pylori infection
reduces S. typhimurium-induced cecal inflammatory cyto-
kines and histologic inflammation, but a histological differ-
ence in fibrosis was difficult to demonstrate using this
chronic model, especially in a model that induced fibrosis.
As H. pylori was shown to influence distant intestinal
immune responses, S. typhimurium numerically reduced the
severity of gastritis in H. pylori-infected hosts. This is con-
sistent with the report by Lemke et al18 that a lower bowel
bacterium can influence gastritis. Whether this represents a
systemic endotoxic tolerance induced by S. typhimurium
remains to be seen. Another potential mechanism is the
alteration of the gut microbiota by S. typhimurium, which
could alter the immune responses at a different site. This
concept has been previously demonstrated, in that antibi-
otic-induced dysbiosis can alter pulmonary responses to
mucosal pathogens.19 This crosstalk may be historically and
evolutionarily important, as monoinfection is uncommon in
areas with poor public hygiene, and colonization with multi-
ple organisms is the rule, rather than the exception. In fact,
colonization with H. pylori might have conferred a selective
advantage in the millennium when a pandemic of typhoid
fever shifted the Greek balance of power from Athens to
Sparta,20 and the conquests of Alexander the Great may
have come to an end due to typhoid.21 The potential power
of the evolutionary selective pressure of Salmonella typhi is
demonstrated by the prevalence of heterozygosity for CFTR
mutations, as the heterozygous state for cystic fibrosis con-
fers a selective advantage through protection from S. typhi.22
It is speculative, but attractive, to consider the possibility
that lethal gut infections like Salmonella may have selected
for the survival of humans who were colonized with and
immunologically tolerant to H. pylori.
In summary, our study demonstrated a potential
mechanism to explain the observed negative association
between H. pylori and IBD. H. pylori-infected hosts dem-
onstrated an increased level of IL-10 in mesenteric lymph
nodes and a repressed lower GI Th17 response to S. typhi-
murium. These findings provide mechanistic support for the
protective role of H. pylori, but prospective studies of the
effect of H. pylori eradication on the risk of developing
IBD will be required to prove the beneficial role of
H. pylori for IBD prevention.
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